Biogen Inc (BIIB) to Post Q1 2017 Earnings of $4.65 Per Share, Leerink Swann Forecasts

Biogen Inc (BIIB) to Post Q1 2017 Earnings of $4.65 Per Share, Leerink Swann Forecasts


Leerink Swann dropped their Q1 2017 earnings per share estimates for shares of Biogen in a note issued to investors on Thursday. Leerink Swann analyst G. Porges now expects that the firm will post earnings per share of $4.65 for the quarter, down from their prior forecast of $4.70.



from Biotech News